Comparison

Verucerfont European Partner

Item no. TMO-T7361-2mg
Manufacturer TargetMol
CASRN 885220-61-1
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles CC[C@H](Nc1cc(C)nc2c(c(C)nn12)-c1ccc(OC)cc1C)c1nc(C)no1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias NBI77860,GSK561679
Shipping Condition Cool pack
Available
Manufacturer - Targets
CRFR
Storage Conditions
-20
Molecular Weight
406.48
Description
Verucerfont (NBI77860) is an antagonist of corticotropin-releasing factor receptor 1 (CRF1) .
Pathways
GPCR/G Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close